Cargando…

PReS-FINAL-2134: Assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (TCZ): 2-year results from the tender trial

Detalles Bibliográficos
Autores principales: Malattia, C, Ruperto, N, Palmisani, E, Pederzoli, S, Pistorio, A, Brunner, HI, Cuttica, R, Calvo, I, Garay, SM, Eleftheriou, D, Wouters, C, Wang, J, Devlin, C, Lovell, D, Martini, A, De Benedetti, F, Ravelli, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044553/
http://dx.doi.org/10.1186/1546-0096-11-S2-P147
_version_ 1782319164758687744
author Malattia, C
Ruperto, N
Palmisani, E
Pederzoli, S
Pistorio, A
Brunner, HI
Cuttica, R
Calvo, I
Garay, SM
Eleftheriou, D
Wouters, C
Wang, J
Devlin, C
Lovell, D
Martini, A
De Benedetti, F
Ravelli, A
author_facet Malattia, C
Ruperto, N
Palmisani, E
Pederzoli, S
Pistorio, A
Brunner, HI
Cuttica, R
Calvo, I
Garay, SM
Eleftheriou, D
Wouters, C
Wang, J
Devlin, C
Lovell, D
Martini, A
De Benedetti, F
Ravelli, A
author_sort Malattia, C
collection PubMed
description
format Online
Article
Text
id pubmed-4044553
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40445532014-06-19 PReS-FINAL-2134: Assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (TCZ): 2-year results from the tender trial Malattia, C Ruperto, N Palmisani, E Pederzoli, S Pistorio, A Brunner, HI Cuttica, R Calvo, I Garay, SM Eleftheriou, D Wouters, C Wang, J Devlin, C Lovell, D Martini, A De Benedetti, F Ravelli, A Pediatr Rheumatol Online J Poster Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4044553/ http://dx.doi.org/10.1186/1546-0096-11-S2-P147 Text en Copyright © 2013 Malattia et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Malattia, C
Ruperto, N
Palmisani, E
Pederzoli, S
Pistorio, A
Brunner, HI
Cuttica, R
Calvo, I
Garay, SM
Eleftheriou, D
Wouters, C
Wang, J
Devlin, C
Lovell, D
Martini, A
De Benedetti, F
Ravelli, A
PReS-FINAL-2134: Assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (TCZ): 2-year results from the tender trial
title PReS-FINAL-2134: Assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (TCZ): 2-year results from the tender trial
title_full PReS-FINAL-2134: Assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (TCZ): 2-year results from the tender trial
title_fullStr PReS-FINAL-2134: Assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (TCZ): 2-year results from the tender trial
title_full_unstemmed PReS-FINAL-2134: Assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (TCZ): 2-year results from the tender trial
title_short PReS-FINAL-2134: Assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (TCZ): 2-year results from the tender trial
title_sort pres-final-2134: assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (tcz): 2-year results from the tender trial
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044553/
http://dx.doi.org/10.1186/1546-0096-11-S2-P147
work_keys_str_mv AT malattiac presfinal2134assessmentofradiographicprogressioninpatientsptswithsystemicjuvenileidiopathicarthritissjiatreatedwithtocilizumabtcz2yearresultsfromthetendertrial
AT ruperton presfinal2134assessmentofradiographicprogressioninpatientsptswithsystemicjuvenileidiopathicarthritissjiatreatedwithtocilizumabtcz2yearresultsfromthetendertrial
AT palmisanie presfinal2134assessmentofradiographicprogressioninpatientsptswithsystemicjuvenileidiopathicarthritissjiatreatedwithtocilizumabtcz2yearresultsfromthetendertrial
AT pederzolis presfinal2134assessmentofradiographicprogressioninpatientsptswithsystemicjuvenileidiopathicarthritissjiatreatedwithtocilizumabtcz2yearresultsfromthetendertrial
AT pistorioa presfinal2134assessmentofradiographicprogressioninpatientsptswithsystemicjuvenileidiopathicarthritissjiatreatedwithtocilizumabtcz2yearresultsfromthetendertrial
AT brunnerhi presfinal2134assessmentofradiographicprogressioninpatientsptswithsystemicjuvenileidiopathicarthritissjiatreatedwithtocilizumabtcz2yearresultsfromthetendertrial
AT cutticar presfinal2134assessmentofradiographicprogressioninpatientsptswithsystemicjuvenileidiopathicarthritissjiatreatedwithtocilizumabtcz2yearresultsfromthetendertrial
AT calvoi presfinal2134assessmentofradiographicprogressioninpatientsptswithsystemicjuvenileidiopathicarthritissjiatreatedwithtocilizumabtcz2yearresultsfromthetendertrial
AT garaysm presfinal2134assessmentofradiographicprogressioninpatientsptswithsystemicjuvenileidiopathicarthritissjiatreatedwithtocilizumabtcz2yearresultsfromthetendertrial
AT eleftherioud presfinal2134assessmentofradiographicprogressioninpatientsptswithsystemicjuvenileidiopathicarthritissjiatreatedwithtocilizumabtcz2yearresultsfromthetendertrial
AT woutersc presfinal2134assessmentofradiographicprogressioninpatientsptswithsystemicjuvenileidiopathicarthritissjiatreatedwithtocilizumabtcz2yearresultsfromthetendertrial
AT wangj presfinal2134assessmentofradiographicprogressioninpatientsptswithsystemicjuvenileidiopathicarthritissjiatreatedwithtocilizumabtcz2yearresultsfromthetendertrial
AT devlinc presfinal2134assessmentofradiographicprogressioninpatientsptswithsystemicjuvenileidiopathicarthritissjiatreatedwithtocilizumabtcz2yearresultsfromthetendertrial
AT lovelld presfinal2134assessmentofradiographicprogressioninpatientsptswithsystemicjuvenileidiopathicarthritissjiatreatedwithtocilizumabtcz2yearresultsfromthetendertrial
AT martinia presfinal2134assessmentofradiographicprogressioninpatientsptswithsystemicjuvenileidiopathicarthritissjiatreatedwithtocilizumabtcz2yearresultsfromthetendertrial
AT debenedettif presfinal2134assessmentofradiographicprogressioninpatientsptswithsystemicjuvenileidiopathicarthritissjiatreatedwithtocilizumabtcz2yearresultsfromthetendertrial
AT ravellia presfinal2134assessmentofradiographicprogressioninpatientsptswithsystemicjuvenileidiopathicarthritissjiatreatedwithtocilizumabtcz2yearresultsfromthetendertrial